facial pore
Conditions
Interventions
self-control:1565nmFANL
Sponsors
Shanghai 9th People's Hospital Shanghai Jiaotong University, School of Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: 1) Aged 18-65 years; 2) healthy patient; 3) Having not accepted any laser or injection treatment in at least 6 months; 4) Having not accepted any oral drugs which will affect blood clotting; 5) Ability and willingness to sign an inform consent form after fully understanding the therapeutic and follow-up strategies.
Exclusion criteria
Exclusion criteria: 1) Insufficient pulmonary functions and hepatorenal functions; 2) Patients with fever or WBC less than 2500 / cubic millimeter; 3) The combined use of other drugs which will affect blood clotting; 4) Serious underlying systemic disease requiring treatment until illness either completes therapy or achieves clinical stablility on therapy for at least 6 months before enrolled the study. The systemic diseases include insufficient pulmonary functions(COPD, pneumonia, pulmonary fibrosis and asthma), insufficient cardiac and hepatorenal functions, infection , hemorrhagic tendency, immunologic disease(SLE, urticaria, HIV); 5) Patient who had accepted any laser or injection treatment in 6 months. The termination criteria to a subject 1) The four times 1565nm FNAL treatment is finished; 2) The subject requests to terminate treatments; 3) Serious major complications classified by the SIR occurs; 4) The subject becomes pregnant.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| number of facial pores; | — |
Countries
China
Contacts
Public ContactXiaoxi Lin
Shanghai 9th People's Hospital Shanghai Jiaotong University, School of Medicine
Outcome results
None listed